Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The related topics section has been stripped of the items 'Multiple myeloma', 'related topics:', and 'MedlinePlus Genetics'. This removes those navigation links from the page's supplementary topic area.
    Difference
    0.1%
    Check dated 2026-05-23T13:18:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A new revision label v3.5.4 has been added, signaling a minor platform update. The previous revision label v3.5.3 has been removed, without affecting study content or page functionality.
    Difference
    0.0%
    Check dated 2026-05-16T09:25:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added related topics entries for Multiple myeloma and MedlinePlus Genetics under the related topics section to provide background resources.
    Difference
    0.1%
    Check dated 2026-05-09T11:23:15.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The Taiwan site entry was updated from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333.
    Difference
    0.0%
    Check dated 2026-05-02T05:08:58.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page’s interface version or release revision indicator was updated from v3.5.2 to v3.5.3. This represents a system display/update rather than a change to the clinical trial details.
    Difference
    0.0%
    Check dated 2026-04-24T22:41:23.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    MRD and PFS endpoints have been updated to IMWG 2025 terminology and subgroups, with added notes on next‑generation sequencing and longer follow-up. The study location count changed from 217 to 209 locations.
    Difference
    1%
    Check dated 2026-04-17T14:13:47.000Z thumbnail image

Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.